Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

Recruiting now

Conditions studied: Tricuspid Regurgitation, Right Heart Failure, Cardiac Remodeling, Ventricular, Cardiac Remodeling, Atrial

In brief

The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.

Key facts

Study ID

NCT05179616

Run by

Helios Klinikum Pforzheim

People needed

200

Starts

2020-11-30

Expected to finish

2026-11-30

Last updated by the study team

2023-09-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects (>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
• Subjects eligible to receive the TriClip™
• Subjects must provide written informed consent prior to study procedure.

You may not qualify if…

• Subjects participating in another clinical study that may impact the follow-up or results of this study.

Where it is running

• Helios Klinikum Pforzheim — Pforzheim, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.